Fluorinated benzamide neuroleptics—III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer
References (37)
- et al.
Synthesis and binding properties of the fluorinated substituted benzamide3H-NCQ 115, a new selective dopamine D-2 receptor ligand
Eur. J. Pharmacol.
(1991) - et al.
Synthesis and evaluation of high affinity, aryl-substituted18F-fluoropropylbenzamides for dopamine D-2 receptor studies
Nucl. Med. Biol.
(1992) Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC
J. Pharmacol. Meth.
(1985)- et al.
LIGAND: a versatile computerized approach for characterization of ligand binding systems
Anal. Biochem.
(1980) Use of diethylaminosulfur trifluoride in an efficient synthesis of (S)-N-[(1-ethyl-2-pyrrolidinyl)-methyl]-5-(3-fluoropropyl)-2-methoxybenzamide
J. Fluorine Chem.
(1990)Fluorinated benzamide neuroleptics 2. Synthesis and radiosynthesis of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(3-18F-fluoropropyl)-3-substituted-2-methoxybenzamide
Int. J. Appl. Radiat. Isotopes
(1991)- et al.
Dopamine D-2 receptors imaged by PET in Cebus apella using18F-benzamide neuroleptic
Eur. J. Pharmacol.
(1990) - et al.
Optically active benzamides as predictive tools for mapping the dopaminergic D-2 receptor
Eur. J. Pharmacol.
(1990) - et al.
Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]- substituted benzamides
J. Pharm. Sci.
(1994) - et al.
Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)- substituted benzamides
J. Med. Chem.
(1991)
Quantitative localization of the D-1 and D-2 subtypes of dopamine receptors in rat brain
J. Neurosci.
(1986)
Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction
Biochem. Pharmacol.
(1973)
Pharmacological profile of SCH 39166: a dopamine D-1 selective benzonaphthazepine with potential antipsychotic activity
J. Pharm. Exp. Therap.
(1988)
Fluorinated and iodinated dopamine agents: D-2 imaging agents for PET and SPECT
J. Med. Chem.
(1993)
Lipophilicity measurements of protonated basic compounds by reversed-phase high performance liquid chromatography
J. Chromatogr.
(1985)
Alternate syntheses of125I-ioxipride and125I-epidepride: high affinity and selective dopamine D-2 receptor radioligands
J. Nucl. Med.
(1992)
Preparation of two highly potent and selective dopamine D-2 receptor antagonists for PET:18F-NCQ 616 and11C-FLB 457
J. Label. Compds Radiopharm.
(1993)
Syntheses of o- and p-18F-fluorobenzyl bromide and their application to preparation of F-18 labeled neuroleptics
J. Label. Compds Radiopharm.
(1991)
Cited by (0)
Presented in part at the Sixth Symposium on the Medical Applications of Cyclotrons, 1–4 June 1992, Turku, Finland and at the 40th Annual Meeting Society of Nuclear Medicine, Toronto, Canada 8–11 June 1993.
Copyright © 1995 Published by Elsevier Inc.